IAS AIDS 2026 took place at a pivotal moment for the global HIV response. Decades of progress are increasingly fragile, with rising HIV notifications in parts of Latin America, the Philippines, Eastern Europe and Central Asia occurring alongside funding reductions, increasing criminalisation and discrimination, persistent inequality and geopolitical change.
The conference nevertheless carried a strong message of determination. Thirty years of effective antiretroviral therapy, U=U, increasingly effective PrEP, long-acting treatment and prevention, and continued vaccine and cure research demonstrate extraordinary scientific progress. But HIV is not finished business, and scientific success alone will not determine future outcomes.
Rights. Science. Financing.
Across sessions, the strongest cross-cutting message was that access, affordability, equity, choice and implementation must develop alongside innovation. New technologies have limited impact if the people who need them cannot obtain or use them.
“It isn’t innovation without access.”
A second major message was that HIV care must increasingly respond to the whole person. Mental health, trauma, stigma, migration, gender, sexuality, alcohol and other drug use, social isolation, ageing, treatment fatigue and healthcare access all shape engagement with prevention and treatment.
Peer and community leadership were consistently recognised as evidence-based components of quality HIV care. As HIV medicine becomes more sophisticated, Peer Navigation may become more important—not less—because people will need trusted support to understand choices, navigate systems and connect clinical care with the realities of everyday life.
The conference also pointed to a changing global HIV architecture: greater domestic and regional leadership, more integration with primary healthcare, stronger focus on sustainable financing, and renewed debate about how community leadership and human rights are protected as systems change. The challenge is not to recreate the past, but to build a response beyond 2030 that combines science, rights, sustainable financing, community leadership and equitable access.
Key Themes seen at AIDS 2026
A New Global HIV Architecture: Sovereignty, Sustainability and Leadership
Global HIV financing and leadership are shifting. Countries and regions are increasingly seeking to set their own priorities, strengthen domestic financing, build local manufacturing capacity and integrate HIV within broader health systems and primary care. Regional leadership, including Africa CDC, was highlighted as part of this shift.
Key takeaway: The future response is likely to be more locally financed, regionally organised and nationally led. Greater sovereignty must strengthen, not weaken community leadership, human rights and equitable access.
Innovation + Access: Scientific Progress Must Reach People
Long-acting treatment, prevention technologies, vaccines, cure research and digital tools demonstrate rapid scientific progress. Long-acting treatment may reduce treatment fatigue, privacy concerns and adherence difficulties, while cure science continues to advance but remains experimental.
Key takeaway: Innovation should be judged not only by what science can develop, but by whether communities can access and benefit from it. Equitable implementation must be planned alongside product development.
Community Power, Human Rights and Decriminalisation
Criminalisation and discrimination remain major threats to HIV outcomes, with organised conservative movements challenging HIV, LGBTQ+ and sexual health responses in many settings. The conference reinforced that biomedical advances cannot substitute for legal reform, bodily autonomy, protection from discrimination and meaningful investment in community organisations and youth leadership.
Key takeaway: Human rights and community power are core public-health interventions, not secondary social considerations.
Prevention is Moving from a Product Model to a Choice Model
PrEP works, but access remains the limiting factor. Prevention is moving toward greater choice across formulations, dosing schedules and delivery settings, including long-acting injections, twice-yearly options, pharmacy and community delivery, and future multipurpose technologies.
Key takeaway: Choice, accessibility and individual preference should increasingly underpin prevention strategy. More options increase potential uptake only when those options are available, affordable and acceptable.
Peer Support Is Evidence-Based HIV Care
Across settings, peer support improved engagement, wellbeing, community connection and quality of life. Internationally, there is growing interest in formal peer workforce structures, recognised training, practice standards, supervision and stronger integration with clinical care.
The question is no longer whether peer support works, but how to make it routine within high-quality HIV care.
Key takeaway: Peer Navigation should be positioned as an evidence-based component of the HIV care pathway, with outcomes measured beyond service volume to include confidence, engagement, social connection, treatment literacy and reduced isolation.
Gender-Affirming Care Is HIV Prevention
Barriers to gender-affirming healthcare can reduce trust, weaken engagement with services and increase HIV vulnerability. Integrating gender-affirming care within HIV programmes can improve prevention, retention, health outcomes, dignity and autonomy.
Key takeaway: Gender-affirming care is both a human rights imperative and an effective HIV prevention strategy, particularly when delivered through community-led and person-centred models.
Mental Health and Trauma Are HIV Issues
Mental-health and trauma-focused interventions improved psychological outcomes while also supporting ART adherence, clinic attendance, retention and viral suppression. Peer and participatory approaches supported implementation and engagement.
“We cannot treat the virus without treating the trauma.”
Key takeaway: Trauma-informed, integrated mental-health and HIV care should be viewed as part of effective HIV treatment, not as an optional add-on.
Responsible AI and the Digital HIV Response
AI-supported navigation, digital adherence tools, smart testing and secure mobile applications may improve access and convenience, particularly for younger people and those seeking discreet support. However, privacy, confidentiality, data security and clinical oversight are critical.
Key takeaway: AI should augment, not replace, human-centred care. Community co-design, ethical governance, human oversight and evidence of effectiveness must accompany implementation.
The Future of HIV Prevention: Vaccines Still Matter
HIV vaccine research continues despite previous setbacks, with newer platforms and more targeted immune approaches under investigation. Vaccines and PrEP were framed as complementary rather than competing strategies, and community trust and vaccine confidence remain essential.
Key takeaway: An effective vaccine remains an important long-term goal, but scientific discovery will only translate into impact through community partnership, confidence and equitable access.
Migration and Mobility Create Hidden HIV Access Barriers
Visa status, healthcare eligibility, insurance, employment, language, stigma, isolation and unfamiliarity with health systems can interrupt prevention and treatment. Digital peer outreach showed promise for populations hesitant to use conventional services.
Key takeaway: Navigation for migrant communities must address the system around the person, not only HIV medication or clinical care.
Community Evidence and Lived Experience Matter
Clinical and surveillance systems do not capture every barrier communities experience. Community-led monitoring can identify stigma, violence, discrimination, service barriers and emerging needs that conventional datasets miss. Protecting anonymity, cybersecurity and community control of data is increasingly important.
Key takeaway: Lived experience is evidence. Community organisations should strengthen how they capture and use qualitative and peer-generated information to influence services, policy and funding.
The Future Requires New Leadership Beyond 2030
Funding cuts, political shifts and changing international structures mean the next era of HIV will look different from the last. Integration with broader health systems will increase, but this must not erode specialist HIV expertise or community infrastructure.
We cannot go back. We cannot stand still.
Key takeaway: The response beyond 2030 needs a renewed narrative built on community leadership, human rights, sustainable financing, integration, innovation and continued ambition.
